Abbott to Acquire St. Jude Medical
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/10/2026
- Wall Street ends down as expectations of Hormuz deal fade
- JPMorgan lifts S&P 500 target to 8,000 on strong earnings
- Nvidia and Wall Street giants plan $500B AI funding deal, FT reports
- Jefferies cuts Apple rating as higher-priced iPhone roadmap looks difficult
- Oil climbs 5% as Iran, US both demand compensation and Hormuz hopes fade
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
S&P Affirms Negative Outlook on Abbott (ABT) Amid Move to Acquire St. Jude Medical (STJ)
April 28, 2016 11:38 AM EDTStandard & Poor's Ratings Services stated that its ratings on Abbott Laboratories (NYSE: ABT), including the 'A+' corporate credit and 'A-1+' commercial paper ratings, remain on CreditWatch with negative implications. The CreditWatch update follows Abbott's offer to acquire St. Jude Medical for roughly $31 billion (including $6 billion of assumed St. Jude debt). This transaction is in addition to the planned roughly $9 billion debt-funded acquisition of Alere.
"We believe that when completed, the acquisition of St. Jude Medical would significantly strengthen Abbott's position in the medical device industry as well as broaden its already very... More
Abbott (ABT), St. Jude (STJ) Deal Carries $685M Termination Fee
April 28, 2016 7:13 AM EDTAbbott (NYSE: ABT) filed the agreement terms of its proposed takeover of St. Jude Medical (NYSE: STJ). The following was noted on Thursday:
Section 10.03 Termination Fees.
(a) In the event that... More
